Intra-Tumoral Lymphocyte Therapy: Treatment for Tumors

Introducing our groundbreaking Intra-Tumoral Lymphocyte Therapy, developed by Beijing BIOOCUS Biotech Ltd. This innovative treatment harnesses the power of the body's own immune system to target and destroy cancerous tumors, Our therapy involves isolating tumor-infiltrating lymphocytes from a patient's own tumor tissue. These specialized immune cells are then expanded and activated ex vivo before being reinfused into the patient's tumor. Once inside the tumor microenvironment, the lymphocytes seek out and attack cancer cells, effectively shrinking the tumor and preventing further growth, This personalized approach to cancer treatment offers a promising new option for patients with solid tumors that have not responded to traditional treatments. In clinical trials, our Intra-Tumoral Lymphocyte Therapy has shown remarkable efficacy with minimal side effects, making it a potentially game-changing treatment for cancer patients, At Beijing BIOOCUS Biotech Ltd., we are committed to advancing the forefront of cancer therapy and improving the lives of patients. Contact us to learn more about our revolutionary Intra-Tumoral Lymphocyte Therapy and how it can benefit your patients